CORS Annual Conference 2017: Transparency in regulatory decision making - opinions, examples and perspectives – University of Copenhagen

Department of Pharmacy > Calendar > CORS Annual Conference...

CORS Annual Conference 2017: Transparency in regulatory decision making - opinions, examples and perspectives

We are pleased to announce the Copenhagen Centre for Regulatory Science 3rd annual conference.

In response to recent calls for more transparency in drug regulation, numerous and diverse initiatives have been launched. Many of these activities have centred on utilising structured approaches to support regulatory decision-making and to broaden the communication of its procedures and outcomes.

This conference will feature speakers from relevant stakeholder group such as regulators, industry, academia and patients. They will present their views on the efforts to improve transparency in regulatory decision-making and future needs to accommodate transparency in regulatory decision-making balancing the Protection of Personal Data (PPD) as well as Commercial Confidential Information (CCI).

Keynote speakers

Keynote speakers will present the past and future of transparency in drug regulation. Professor Ragnar Löfstedt and Dr. Dominic Way will provide an overview of the recent history of transparency in drug regulation – what steps have been taken and which should be taken. And as medical practice and innovation is increasingly more influenced by the availability of ‘big data’, complex medical algorithms take a more central role.
Dr. Nicholson Price will present research on the opportunities medical algorithms bring to medical innovation and the challenges they pose to regulators.

Ragnar E. Löfstedt is Professor of Risk Management and the Director of King's Centre for Risk Management, King's College London, UK where he teaches and conducts research on risk communication and management. He has conducted research in risk communication and management in such areas as renewable energy policy, transboundary environmental issues (acid rain and nuclear power), health and safety, telecommunications, biosafety, pharmaceuticals, and the siting of building of incinerators, fuel policy, nuclear waste installations and railways. He is a believer in the building of public trust in regulators and industry via proactive risk communication and argues that high regulatory/industry trust is equivalent to low public perceived risk.
Dr Löfstedt is the author/editor of ten books and over 90 peer reviewed articles/book chapters. He is the editor-in-chief for Journal of Risk Research and editor of the Risk in Society book series from Earthscan.
He also serves on the editorial boards of International Journal of Risk Assessment and Management, European Journal of Risk Regulation, Journal of Health Communication, Risk Management, and SAPIENS.

Dominic Way holds a PhD in Geography (Centre for Risk Management) at King’s College London. Dominic's primary research focuses on the history, idea and concept of ‘transparency’ as well as empirically measuring and evaluating the effects of various transparency policies on building trust in institutions and confidence in decision-makers (esp. the European Medicines Agency and European Food Safety Authority).
He has written about and lectured on risk regulation, management, communication and assessment - such as on transparency, behavioural economics, patient safety, pharmaceuticals, food safety and chemical policy - to both public and private institutions at international conferences, workshops and other events (e.g. at the US Food and Drug Administration, Health Canada and many EU regulatory agencies).
He has also lectured MSc students as a visiting research fellow at Maastricht University, organised numerous high-level international workshops on transparency and is an active member of the Society for Risk Analysis (2011-2016): treasurer/secretary for the Risk, Policy and Law Speciality Group (2013-2016).

Nicholson Price is an Assistant Professor of Law at the University of Michigan Law School. He holds a PhD in Biology and a JD, both from Columbia, and an AB from Harvard.
He teaches patents and health law, and studies innovation in the life sciences, with a recent focus on big data and machine learning in medicine. His work has appeared in Nature, Science, Nature Biotechnology, the Michigan Law Review, the Harvard Journal of Law and Technology, and elsewhere.
Nicholson is a cofounder of Regulation and Innovation in the Biosciences and co-chair of the Junior IP Scholars Association.

Program and registration

Please have a look at our full Program (pdf).